It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
In April 2020, Kirsch founded the COVID-19 Early Treatment Fund (CETF) to fund research into off-label treatments for COVID-19 among drugs already having FDA approval for other diseases, donating $1 million himself and also fundraising from others. He recruited what MIT Technology Review called "a powerhouse board" of scientific advisors including Robert Siliciano and management by Rockefeller Philanthropy Advisors. By October 2021 the fund had made grants totaling $4.5 million to various researchers.
The fund found a "promising candidate" for further study in fluvoxamine, according to MIT Technology Review. After funding a successful small trial which ended in November 2020, CETF provided further funding for a Phase 3 trial, which as of October 2021 was analyzing data. Kirsch, frustrated that CETF's scientific advisory board was not willing to promote use of the drug based on results of a small preliminary study, wrote a post on Medium titled The Fast, Easy, Safe, Simple, Low-Cost Solution to COVID That Works 100% of the Time That Nobody Wants to Talk About.
Medium removed his access to the site, citing misinformation concerns. Kirsch also refused to accept the outcome of a CETF-funded study on hydroxychloroquine, which had found the drug ineffective; he eventually warred with CETF's scientific advisory board over CETF's treatment of both drugs to the extent that in May 2021 all 12 members resigned.
originally posted by: vNex92
a reply to: v1rtu0s0
I wonder what those doctors knew or what they found?
originally posted by: Annee
Steve Kirsch
In April 2020, Kirsch founded the COVID-19 Early Treatment Fund (CETF) to fund research into off-label treatments for COVID-19 among drugs already having FDA approval for other diseases, donating $1 million himself and also fundraising from others. He recruited what MIT Technology Review called "a powerhouse board" of scientific advisors including Robert Siliciano and management by Rockefeller Philanthropy Advisors. By October 2021 the fund had made grants totaling $4.5 million to various researchers.
The fund found a "promising candidate" for further study in fluvoxamine, according to MIT Technology Review. After funding a successful small trial which ended in November 2020, CETF provided further funding for a Phase 3 trial, which as of October 2021 was analyzing data. Kirsch, frustrated that CETF's scientific advisory board was not willing to promote use of the drug based on results of a small preliminary study, wrote a post on Medium titled The Fast, Easy, Safe, Simple, Low-Cost Solution to COVID That Works 100% of the Time That Nobody Wants to Talk About.
Medium removed his access to the site, citing misinformation concerns. Kirsch also refused to accept the outcome of a CETF-funded study on hydroxychloroquine, which had found the drug ineffective; he eventually warred with CETF's scientific advisory board over CETF's treatment of both drugs to the extent that in May 2021 all 12 members resigned.
en.wikipedia.org...
originally posted by: v1rtu0s0
originally posted by: Annee
Steve Kirsch
In April 2020, Kirsch founded the COVID-19 Early Treatment Fund (CETF) to fund research into off-label treatments for COVID-19 among drugs already having FDA approval for other diseases, donating $1 million himself and also fundraising from others. He recruited what MIT Technology Review called "a powerhouse board" of scientific advisors including Robert Siliciano and management by Rockefeller Philanthropy Advisors. By October 2021 the fund had made grants totaling $4.5 million to various researchers.
The fund found a "promising candidate" for further study in fluvoxamine, according to MIT Technology Review. After funding a successful small trial which ended in November 2020, CETF provided further funding for a Phase 3 trial, which as of October 2021 was analyzing data. Kirsch, frustrated that CETF's scientific advisory board was not willing to promote use of the drug based on results of a small preliminary study, wrote a post on Medium titled The Fast, Easy, Safe, Simple, Low-Cost Solution to COVID That Works 100% of the Time That Nobody Wants to Talk About.
Medium removed his access to the site, citing misinformation concerns. Kirsch also refused to accept the outcome of a CETF-funded study on hydroxychloroquine, which had found the drug ineffective; he eventually warred with CETF's scientific advisory board over CETF's treatment of both drugs to the extent that in May 2021 all 12 members resigned.
en.wikipedia.org...
Yes we know wikipedia is controlled by the deep state / WEF / NWO.
Disclaimer
originally posted by: v1rtu0s0
originally posted by: UpThenDown
originally posted by: v1rtu0s0
a reply to: Kenzo
Is your thread about these doctors, if so is the title correct....14 young
I mean I am not entering the debate over what killed them but if that picture is of the dead then there is only one which could be classed as young and there is only 13
Why use MSM tactics in your headline?
originally posted by: UpThenDown
a reply to: v1rtu0s0
I am basing it on your image, you always provide accurate information, so why would I look elsewhere,
do you believe they are classed as young?